Article Versions Notes

Weng K-P, Chien K-J, Huang S-H, Huang L-H, Lin P-H, Lin Y, Chang W-H, Chen C-Y, Li S-C. iTRAQ Proteomics Identified the Potential Biomarkers of Coronary Artery Lesion in Kawasaki Disease and In Vitro Studies Demonstrated That S100A4 Treatment Made HCAECs More Susceptible to Neutrophil Infiltration. International Journal of Molecular Sciences. 2022; 23(21):12770. https://doi.org/10.3390/ijms232112770

Weng, Ken-Pen, Kuang-Jen Chien, Shih-Hui Huang, Lien-Hung Huang, Pei-Hsien Lin, Yuyu Lin, Wei-Hsiang Chang, Chun-Yu Chen, and Sung-Chou Li. 2022. "iTRAQ Proteomics Identified the Potential Biomarkers of Coronary Artery Lesion in Kawasaki Disease and In Vitro Studies Demonstrated That S100A4 Treatment Made HCAECs More Susceptible to Neutrophil Infiltration" International Journal of Molecular Sciences 23, no. 21: 12770. https://doi.org/10.3390/ijms232112770

Weng, K.-P., Chien, K.-J., Huang, S.-H., Huang, L.-H., Lin, P.-H., Lin, Y., Chang, W.-H., Chen, C.-Y., & Li, S.-C. (2022). iTRAQ Proteomics Identified the Potential Biomarkers of Coronary Artery Lesion in Kawasaki Disease and In Vitro Studies Demonstrated That S100A4 Treatment Made HCAECs More Susceptible to Neutrophil Infiltration. International Journal of Molecular Sciences, 23(21), 12770. https://doi.org/10.3390/ijms232112770